2-Arachidonoyl glycerol induces contraction of isolated rat aorta: Role of cyclooxygenase-derived products

Cardiovascular Research

Volumn 63, Issue 1, 2004, Pages 155-160

  Stanke Labesque, Françoise ^a   Mallaret, Michel ^a   Lefebvre, Blandine ^a   Hardy, Gaëlle ^a   Caron, Françoise ^a   Bessard, Germain ^a  

^a University Grenoble Alpes   (France)

Author keywords

2 Arachidonoyl glycerol; Cyclooxygenases; Rat aorta; Thromboxane

Indexed keywords

2 ARACHIDONOYLGLYCEROL; 5 (4 CHLORO 3 METHYLPHENYL) 1 (4 METHYLBENZYL) N (1,3,3 TRIMETHYLBICYCLO[2.2.1]HEPTAN 2 YL) 3 PYRAZOLECARBOXAMIDE; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CANNABINOID RECEPTOR ANTAGONIST; INDOMETACIN; PROSTAGLANDIN SYNTHASE; RIMONABANT; THROMBOXANE A2; VAPIPROST;

ANIMAL TISSUE; AORTA CONSTRICTION; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DERIVATIZATION; DRUG EFFECT; ENZYME IMMUNOASSAY; EVOKED RESPONSE; HEART MUSCLE RELAXATION; ISOLATED HEART; NONHUMAN; PRIORITY JOURNAL; RAT; STATISTICAL SIGNIFICANCE; VASCULAR ENDOTHELIUM; VASCULAR RING;

ANIMALS; AORTA; ARACHIDONIC ACIDS; DINOPROST; DINOPROSTONE; ENDOCANNABINOIDS; GLYCERIDES; MALE; MUSCLE, SMOOTH, VASCULAR; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RATS; RATS, INBRED WKY; THROMBOXANE A2; VASOCONSTRICTOR AGENTS;

EID: 2942521098     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2004.03.024     Document Type: Article

References (24)

1. Giuffrida A., Beltramo M., Piomelli D. Mechanisms of endocannabinoid inactivation: biochemistry and pharmacology. J. Pharmacol. Exp. Ther. 298:2001;7-14
2. Gebremedhin D., Lange A.R., Campbell W.B., Hillard C.J., Harder D.R. Cannabinoid CB1 receptor of cat cerebral arterial muscle functions to inhibit L-type Ca2+ channel current. Am. J. Physiol. 276:1999;H2085-H2093
3. Grainger J., Boachie-Ansah G. Anandamide-induced relaxation of sheep coronary arteries: the role of the vascular endothelium, arachidonic acid metabolites and potassium channels. Br. J. Pharmacol. 134:2001;1003-1012
4. Harris D., McCulloch A.I., Kendall D.A., Randall M.D. Characterization of vasorelaxant responses to anandamide in the rat mesenteric arterial bed. J. Physiol. 539:2002;893-902
5. Jarai Z., Wagner J.A., Varga K., et al. Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors. Proc. Natl. Acad. Sci. U. S. A. 96:1999;14136-14141
6. Wagner J.A., Varga K., Jarai Z., Kunos G. Mesenteric vasodilation mediated by endothelial anandamide receptors. Hypertension. 33:1999;429-434
7. Zygmunt P.M., Hogestatt E.D., Waldeck K., et al. Studies on the effects of anandamide in rat hepatic artery. Br. J. Pharmacol. 122:1997;1679-1686
8. Sugiura T., Kodaka T., Nakane S., et al. Detection of an endogenous cannabimimetic molecule, 2-arachidonoylglycerol, and cannabinoid CB1 receptor mRNA in human vascular cells: is 2-arachidonoylglycerol a possible vasomodulator? Biochem. Biophys. Res. Commun. 243:1998;838-843
9. Mechoulam R., Fride E., Ben-Shabat S., Meiri U., Horowitz M. Carbachol, an acetylcholine receptor agonist, enhances production in rat aorta of 2-arachidonoyl glycerol, a hypotensive endocannabinoid. Eur. J. Pharmacol. 362:1998;R1-R3
10. Jarai Z., Wagner J.A., Goparaju S.K., et al. Cardiovascular effects of 2-arachidonoyl glycerol in anesthetized mice. Hypertension. 35:2000;679-684
11. Kagota S., Yamaguchi Y., Nakamura K., et al. 2-Arachidonoylglycerol, a candidate of endothelium-derived hyperpolarizing factor. Eur. J. Pharmacol. 415:2001;233-238
12. Stanke-Labesque F., Devillier P., Veitl S., et al. Cysteinyl leukotrienes are involved in angiotensin II-induced contraction of aorta from spontaneously hypertensive rats. Cardiovasc. Res. 49:2001;152-160
13. White R., Hiley C.R. The actions of the cannabinoid receptor antagonist, SR 141716A, in the rat isolated mesenteric artery. Br. J. Pharmacol. 125:1998;689-696
14. Pertwee R.G. Pharmacology of cannabinoid CB1 and CB2 receptors. Pharmacol. Ther. 74:1997;129-180
15. Beltramo M., Stella N., Calignano A., et al. Functional role of high-affinity anandamide transport, as revealed by selective inhibition. Science. 277:1997;1094-1097
16. Pertwee R.G., Fernando S.R., Griffin G., Abadji V., Makriyannis A. Effect of phenylmethylsulphonyl fluoride on the potency of anandamide as an inhibitor of electrically evoked contractions in two isolated tissue preparations. Eur. J. Pharmacol. 272:1995;73-78
17. Cryer B., Feldman M. Cyclooxygenase-1 and cyclooxygenase-2 selectivity of widely used nonsteroidal anti-inflammatory drugs. Am. J. Med. 104:1998;413-421
18. Lumley P., White B.P., Humphrey P.P. GR32191, a highly potent and specific thromboxane A2 receptor blocking drug on platelets and vascular and airways smooth muscle in vitro. Br. J. Pharmacol. 97:1989;783-794
19. Savinainen J.R., Jarvinen T., Laine K., Laitinen J.T. Despite substantial degradation, 2-arachidonoylglycerol is a potent full efficacy agonist mediating CB(1) receptor-dependent G-protein activation in rat cerebellar membranes. Br. J. Pharmacol. 134:2001;664-672
20. Sugiura T., Kobayashi Y., Oka S., Waku K. Biosynthesis and degradation of anandamide and 2-arachidonoylglycerol and their possible physiological significance. Prostaglandins Leukot, Essent. Fatty Acids. 66:2002;173-192
21. Kozak K.R., Crews B.C., Morrow J.D., et al. Metabolism of the endocannabinoids, 2-arachidonylglycerol and anandamide, into prostaglandin, thromboxane, and prostacyclin glycerol esters and ethanolamides. J. Biol. Chem. 277:2002;44877-44885
22. Coleman R.A., Smith W.L., Narumiya S. International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes. Pharmacol. Rev. 46:1994;205-229
23. Adeagbo A.S., Patel D., Iddrissu A., et al. NS-398, a selective cyclooxygenase-2 blocker, acutely inhibits receptor-mediated contractions of rat aorta: role of endothelium. Eur. J. Pharmacol. 458:2003;145-154
24. Randall M.D., Harris D., Kendall D.A., Ralevic V. Cardiovascular effects of cannabinoids. Pharmacol. Ther. 95:2002;191-202